Viewing Study NCT06153498



Ignite Creation Date: 2024-05-06 @ 7:50 PM
Last Modification Date: 2024-10-26 @ 3:15 PM
Study NCT ID: NCT06153498
Status: RECRUITING
Last Update Posted: 2023-12-13
First Post: 2023-11-23

Brief Title: PKPD Properties and Safety of Remazolam Besylate for Injection in ICU Patients With Impaired Renal Function
Sponsor: Wuhan Union Hospital China
Organization: Wuhan Union Hospital China

Study Overview

Official Title: A Randomized Study of the PKPD Properties and Safety of Remazolam Besylate for Injection in ICU Patients With Impaired Renal Function
Status: RECRUITING
Status Verified Date: 2023-12
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Pharmacokineticpharmacodynamic profiles of remazolam besylate were compared in patients with impaired and normal renal function in the ICU and safety was assessed by recording hemodynamic parameters and adverse events
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None